The treatment will be for adults with aggressive non-Hodgkin’s lymphoma when chemotherapy has failed. It re-engineers a patient’s own cells to fight cancer.
DENISE GRADY, NY Times: Health
Wed, 10/18/2017 - 5:28pm
The treatment will be for adults with aggressive non-Hodgkin’s lymphoma when chemotherapy has failed. It re-engineers a patient’s own cells to fight cancer.